Petros Pharmaceuticals raises $7.5M in registered direct offering and private placement

Petros Pharmaceuticals, Inc.

Sold 2,186,589 shares at $3.43 each to accredited investors, including largest shareholder.
Issued warrants to purchase up to 1,639,942 shares at $3.50, exercisable for five years.
Net proceeds expected ~$6.9M after fees; used for men's health platform expansion and working capital.
Katalyst Securities served as financial advisor; receives $560K fee and 110,000 warrants.
Closing occurred December 27, 2021.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.